PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the target of a large increase in short interest in May. As of May 29th, there was short interest totaling 101,221 shares, an increase of 102.8% from the May 14th total of 49,921 shares. Based on an average trading volume of 20,570 shares, the short-interest ratio is presently 4.9 days.
PureTech Health Price Performance
PTCHF stock opened at $1.70 on Friday. PureTech Health has a 12-month low of $1.55 and a 12-month high of $1.92. The stock’s 50 day simple moving average is $1.73 and its 200 day simple moving average is $1.70.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Featured Articles
- Five stocks we like better than PureTech Health
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
